Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
color, conference, contrast, epidemic, idiopathic, IIM, inflammatory, manifestation, modest, myopathy, necrotizing, robust, Taubmann, underwritten, women, young
Removed:
ASGCT, aspect, bioresearch, Canada, defer, Dermatology, emerge, emergence, emergency, enhancing, furlough, globally, immunosuppressed, interactive, investigation, kidney, myeloma, objection, potentiating, presenting, proceeded, proteome, ranging, remote, resume, showed, sparing, spread, strain, surfaced, undisclosed, Venereology, worsen, Wuhan
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view